Reversible cerebral vasoconstriction syndrome
Information
- Disease name
- Reversible cerebral vasoconstriction syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04463212 | Completed | Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome | January 29, 2021 | January 12, 2024 | |
| NCT04179383 | Recruiting | N/A | Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome | December 5, 2019 | September 2024 |
| NCT05491980 | Recruiting | Florida Cerebrovascular Disease Biorepository and Genomics Center | August 2, 2022 | August 2024 | |
| NCT02756416 | Unknown status | N/A | Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome | July 2016 | May 2017 |
| NCT03509701 | Unknown status | Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus | May 1, 2018 | April 30, 2020 | |
| NCT03150524 | Withdrawn | Phase 4 | RCVS: The Rational Approach to Diagnosis and Treatment | July 1, 2017 | May 31, 2019 |
| NCT04580238 | Withdrawn | Phase 1 | Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache | December 2023 | June 2025 |
- OrphaNumber from OrphaNet (Orphanet)
- 284388